Table 3.
Correlation of EBV-DNA detection in different specimens (EBV+) with EBV seroprevalence in MS patients.
| Correlations in MS patients |
||||||
|---|---|---|---|---|---|---|
| IgG | IgM | Serum | PBMCs | Saliva | CSF | |
| EBV-IgG (U/mL) | ||||||
| Pearson correlation | 1 | −.412 | .437* | .580** | .308 | .244 |
| Sig. (2-tailed) | .209 | .016 | .000 | .057 | .469 | |
| EBV-IgM (U/mL) | ||||||
| Pearson correlation | −.412 | 1 | −.242 | −.286 | −.217 | −.308 |
| Sig. (2-tailed) | .209 | .474 | .393 | .521 | .387 | |
| Serum DNA (copies/mL) | ||||||
| Pearson correlation | .437* | −.242 | 1 | .211 | .436* | .121 |
| Sig. (2-tailed) | .016 | .474 | .264 | .026 | .723 | |
| PBMCs DNA (copies/mL) | ||||||
| Pearson correlation | .580** | −.286 | .211 | 1 | .146 | .314 |
| Sig. (2-tailed) | .000 | .393 | .264 | .380 | .346 | |
| Saliva DNA (copies/mL) | ||||||
| Pearson correlation | .308 | −.217 | .436* | .146 | 1 | −.248 |
| Sig. (2-tailed) | .057 | .521 | .026 | .380 | .463 | |
| CSF DNA (copies/mL) | ||||||
| Pearson correlation | .244 | −.308 | .121 | .314 | −.248 | 1 |
| Sig. (2-tailed) | .469 | .387 | .723 | .346 | .463 | |
*
Correlation is significant at the 0.05 level (2-tailed).
**
Correlation is significant at the 0.01 level (2-tailed).